Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide

摘要

The present invention provides a novel polypeptide which is capable of reducing dichloroindophenol and oxidised glutathione, DNA encoding the novel polypeptide, vectors containing such DNA, hosts transformed with such vectors, antibodies against the novel polypeptide and pharmaceutical compositions containing the novel polypeptide. The novel polypeptide is useful in the treatment of disorders caused by oxidative stress.